Key Technical Specifications
- Rapid time-to-hemostasis (< 2 minutes in clinical models)
- 100% bioabsorbable within 7–14 days without tissue scarring
- Conforms readily to uneven and friable surgical bleeding beds
- Sterile double-barrier blister packaging (SAL 10⁻⁶)
Hemostatic & Surgical Solutions
Active & Absorbable Topical Hemostats
Clinical Overview & Purpose
Topical surgical agents and flowable matrices designed for intraoperative bleeding control and immediate hemostatic support.
Hemostatic & Surgical Solutions encompass advanced active and passive surgical hemostats designed to control intraoperative bleeding effectively and reliably. Formulated from oxidized regenerated cellulose (ORC), collagen sponges, and flowable gelatin-thrombin matrices, these solutions achieve rapid clotting when conventional suture or cautery is insufficient.
Clinical & Engineering Advantages
Rapid Hemostatic Clotting
Arrests persistent capillary, venous, and minor arterial bleeding within minutes to reduce intraoperative blood loss.
Complete Bioabsorption
Fully absorbed by normal enzymatic pathways within 7 to 14 days without foreign body encapsulation or adhesions.
Broad Surface Adaptability
Pliable, cut-to-fit formats conform smoothly to irregular bleeding sites and friable parenchymal organs.
Inherent Antimicrobial Barrier
Provides protective barrier properties against common surgical pathogens at the critical closure site.
Clinical Applications & Suites
- •Cardiovascular, Thoracic & Vascular Surgery
- •General Surgery & Visceral Abdominal Procedures
- •Orthopedic, Joint Replacement & Spinal Surgery
- •Neurosurgical Suites & Trauma Emergency Resuscitation
Standards & Hospital Integration
- CE Marked & ISO 13485 Medical Device Quality Management System Certified
- Full biocompatibility evaluation cleared in compliance with ISO 10993 standards
- Sterility Assurance Level (SAL 10⁻⁶) via validated gamma or ETO terminal sterilization
- Hospital Operating Theater ready-to-use double-barrier sterile packaging